Compare WHG & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WHG | SMTI |
|---|---|---|
| Founded | 1983 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 157.9M | 186.9M |
| IPO Year | 2002 | N/A |
| Metric | WHG | SMTI |
|---|---|---|
| Price | $17.99 | $25.35 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $41.00 |
| AVG Volume (30 Days) | 10.8K | ★ 52.0K |
| Earning Date | 10-30-2025 | 11-12-2025 |
| Dividend Yield | ★ 3.38% | N/A |
| EPS Growth | ★ 154.57 | N/A |
| EPS | ★ 0.82 | N/A |
| Revenue | $96,243,000.00 | ★ $101,877,532.00 |
| Revenue This Year | N/A | $21.60 |
| Revenue Next Year | N/A | $16.70 |
| P/E Ratio | $21.55 | ★ N/A |
| Revenue Growth | 4.20 | ★ 30.52 |
| 52 Week Low | $13.49 | $18.90 |
| 52 Week High | $18.97 | $38.68 |
| Indicator | WHG | SMTI |
|---|---|---|
| Relative Strength Index (RSI) | 70.85 | 56.25 |
| Support Level | $16.12 | $20.06 |
| Resistance Level | $16.75 | $27.00 |
| Average True Range (ATR) | 0.60 | 1.26 |
| MACD | 0.19 | 0.86 |
| Stochastic Oscillator | 92.21 | 72.47 |
Westwood Holdings Group Inc manages investment assets and provides services for clients through subsidiaries. It operates its business through the Advisory and Trust segments. Its advisory segment provides investment advisory services to corporate retirement plans, public retirement plans, endowments, foundations, individuals and the Westwood Funds, as well as investment sub-advisory services to mutual funds and its trust segment. The Trust segment offers trust and custodial services to its clients and its advisory segment sponsors common trust funds to institutions and high net-worth individuals. It generates maximum revenue from the Advisory segment. Geographically, it derives a majority of its revenue from the United States.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.